The steamy Fifty Shades trilogy is gearing up for its departure from Netflix, with all three films set to leave the platform on January 1, 2026. Originally released between 2015 and 2018, the films have been a hot topic due to their racy content and massive box office success. However, despite raking in over a billion dollars worldwide, critical acclaim didn't follow, with the trilogy receiving a mixed reception from audiences and critics alike.
The Fifty Shades films have undeniably been a financial juggernaut. Collectively, they've amassed a whopping $1.325 billion against a modest production budget of $150 million. Here's how each film fared financially: Fifty Shades of Grey (2015) grossed $569.7 million, Fifty Shades Darker (2017) pulled in $381 million, and Fifty Shades Freed (2018) earned $372 million. But, when it comes to critical reviews, the trilogy couldn't quite hit the mark. Rotten Tomatoes scores reveal a rocky relationship with critics, with ratings ranging from 11% to 25% on the Tomatometer.
“Despite the critical panning, the Fifty Shades series has cemented its place in pop culture with its bold storytelling and undeniable allure.”
Based on E.L. James' best-selling novels, the films explore the intricate romance between Anastasia Steele, played by Dakota Johnson, and the enigmatic billionaire Christian Grey, portrayed by Jamie Dornan. The trilogy's first installment was directed by Sam Taylor-Johnson and scripted by Kelly Marcel. James Foley took over directing duties for the sequels, with Niall Leonard handling the screenplay. Notably, music for all three films was composed by the legendary Danny Elfman, adding to the franchise's unique vibe.
Adding depth to the trilogy's narrative, the supporting cast features talents like Eloise Mumford, Victor Rasuk, Luke Grimes, Marcia Gay Harden, Rita Ora, Max Martini, Andrew Airlie, Jennifer Ehle, and Dylan Neal. Produced by Michael De Luca, E.L. James, and Dana Brunetti, the team was later joined by Marucs Viscidi for the final two films, ensuring a consistent yet evolving vision for the series.